Presentation at the International -2-

Date : 06/28/2010 @ 2:00AM
Source : RNS Non-Regulatory
Stock : Immupharma (IMM)
Quote : 119.0  7.5 (6.73%) @ 11:29AM
Immupharma share price Chart

Presentation at the International -2-

world economic downturn threatens the creativity and risk taking so necessary 
for further discovery and the financing of the research, medical education, and 
the delivery of both established and newly discovered therapies that are 
essential for improving the lives of persons with lupus. So LUPUS 2010 occurs at 
a time of real crisis in lupus research and care, a time when the opportunities 
have never been greater, but the perils are also formidable. The goals of LUPUS 
2010 are therefore to emphasize the opportunities while contributing to the 
efforts to diminish the risks to further progress in lupus research, education 
and care. 
The strategy of LUPUS 2010, is to emulate the potlatch of the 
indigenous peoples of the Pacific Northwest, whose cedar long houses became 
centers for the potlatch tradition where participants were hosted and housed. 
Potlatch meaning "to give away" or "gift" were convocations that were carefully 
planned to commemorate significant events in the collective life of an extended 
family or clan. Participants brought gifts and all received gifts. Lupus 2010 
will be a meeting of the extended family of lupus researchers, clinicians, 
educators and persons with lupus that will be carefully planned to optimize the 
exchange of knowledge and understanding. Participants will bring gifts of their 
personal knowledge and understanding and will exchange these gifts with all 
participants. Together, the group will develop a consensus document indicating 
the state of the field and the challenges for the future. It is anticipated that 
the 2010 Potlatch of the lupus clan will reward and enrich all participants and 
point the way toward future developments. 
LUPUS 2010, unlike any of the 
meetings that persons interested in lupus might attend or have attended will be 
distinguished by the active input of all participants and sponsors, its emphasis 
on the next generation, intimate venues designed to be interactive and to break 
down barriers of language, discipline, status, and focus on the overall goal of 
working together to advance the field. Plenary sessions will have broad appeal 
and delivered in a manner to be informative to the expert, but also completely 
comprehensible to the novice. 
LUPUS 2010 will: 
1.     Review 
comprehensively the state of the science and the state of the art in SLE 
 Identify future opportunities in lupus research, education and care 
Identify, assemble, and facilitate the next generation of leaders and provide an 
opportunity for mentoring with  the current 

leaders in SLE

Reduce the cognitive, communication, and conceptual barriers between persons 
with  lupus, health care   providers and 

clinical and basic

researchers from different disciplines, and different cultures 
5.     Close 
the gap between what we know, what we do and what we could do worldwide in SLE 
therapeutis, medical  and 

public education, clinical and

fundamental research 
This information is provided by RNS 
            The company news service from the London Stock Exchange 

Immupharma (LSE:IMM)
Historical Stock Chart

1 Year : From Feb 2017 to Feb 2018

Click Here for more Immupharma Charts.

Immupharma (LSE:IMM)
Intraday Stock Chart

Today : Sunday 18 February 2018

Click Here for more Immupharma Charts.
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V:us D:20180218 07:09:34